Literature DB >> 7543440

Insulin-like growth factor 2 and insulin-like growth factor binding protein 2 expression in hepatoblastoma.

S N Akmal1, K Yun, J MacLay, Y Higami, T Ikeda.   

Abstract

The expression of insulin-like growth factor 2 (IGF2) and insulin-like growth factor binding protein 2 (IGFBP2) in 11 cases of hepatoblastoma was studied by means of in situ mRNA hybridization using digoxigenin (DIG)-labeled riboprobes. The results showed that both IGF2 and IGFBP2 transcripts are present in hepatoblastoma and that their expression is inversely correlated with the degree of tumor cell differentiation. The data suggested that IGF2 and IGFBP2 gene expression could be regarded as a marker for assessment of the degree of differentiation in hepatoblastoma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543440     DOI: 10.1016/0046-8177(95)90005-5

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  11 in total

1.  Modeling prognosis for patients with malignant astrocytic gliomas: quantifying the expression of multiple genetic markers and clinical variables.

Authors:  Yi-Hong Zhou; Kenneth R Hess; Longjian Liu; Mark E Linskey; W K Alfred Yung
Journal:  Neuro Oncol       Date:  2005-10       Impact factor: 12.300

2.  Gene expression profiling of human hepatoblastoma using archived formalin-fixed and paraffin-embedded tissues.

Authors:  Eun Shin; Kyoung-Bun Lee; Soo-Young Park; Soo-Hee Kim; Han-Suk Ryu; Young-Nyun Park; Eunsil Yu; Ja-June Jang
Journal:  Virchows Arch       Date:  2011-03-03       Impact factor: 4.064

3.  IGF binding protein 2 supports the survival and cycling of hematopoietic stem cells.

Authors:  Hoangdinh Huynh; Junke Zheng; Masato Umikawa; Chaozheng Zhang; Robert Silvany; Satoru Iizuka; Martin Holzenberger; Wei Zhang; Cheng Cheng Zhang
Journal:  Blood       Date:  2011-08-05       Impact factor: 22.113

Review 4.  Overgrowth syndromes - clinical and molecular aspects and tumour risk.

Authors:  Frédéric Brioude; Annick Toutain; Eloise Giabicani; Edouard Cottereau; Valérie Cormier-Daire; Irene Netchine
Journal:  Nat Rev Endocrinol       Date:  2019-05       Impact factor: 43.330

Review 5.  IGFBP2: integrative hub of developmental and oncogenic signaling network.

Authors:  Tao Li; M Elizabeth Forbes; Gregory N Fuller; Jiabo Li; Xuejun Yang; Wei Zhang
Journal:  Oncogene       Date:  2020-01-10       Impact factor: 9.867

6.  Molecular Mechanisms of Hepatoblastoma.

Authors:  Yi Zhang; Antonio Solinas; Stefano Cairo; Matthias Evert; Xin Chen; Diego F Calvisi
Journal:  Semin Liver Dis       Date:  2021-01-20       Impact factor: 6.115

7.  Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion.

Authors:  Eun-Ju Lee; Cristian Mircean; Ilya Shmulevich; Huamin Wang; Jinsong Liu; Antti Niemistö; John J Kavanagh; Je-Ho Lee; Wei Zhang
Journal:  Mol Cancer       Date:  2005-02-02       Impact factor: 27.401

8.  Altered expression of members of the IGF-axis in hepatoblastomas.

Authors:  S G Gray; T Eriksson; C Ekström; S Holm; D von Schweinitz; P Kogner; B Sandstedt; T Pietsch; T J Ekström
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

9.  CircHMGCS1 Promotes Hepatoblastoma Cell Proliferation by Regulating the IGF Signaling Pathway and Glutaminolysis.

Authors:  Ni Zhen; Song Gu; Ji Ma; Jiabei Zhu; Minzhi Yin; Min Xu; Jing Wang; Nan Huang; Zhongqi Cui; Zhixuan Bian; Fenyong Sun; Qiuhui Pan
Journal:  Theranostics       Date:  2019-01-25       Impact factor: 11.556

10.  IGF binding protein 2 is a cell-autonomous factor supporting survival and migration of acute leukemia cells.

Authors:  Xiaoli Chen; Junke Zheng; Yizhou Zou; Chun Song; Xuemei Hu; Cheng Cheng Zhang
Journal:  J Hematol Oncol       Date:  2013-10-08       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.